Introduction
============

Percutaneous endoscopic gastrostomy (PEG) is a safe, minimally invasive procedure for long-term enteral nutrition in patients with impaired oral intake [@JR597-1] [@JR597-2] [@JR597-3]. However, aseptic procedure is difficult to maintain in the pull or push technique with the probable transfer of oral bacterial to the stoma site. Peristomal site infection has often been identified as the most common adverse event after PEG tube placements [@JR597-4]. Administration of systemic prophylactic antibiotics has been demonstrated to be effective in reducing peristomal infection and is often employed before the procedure [@JR597-5] [@JR597-6] [@JR597-7]. Nonetheless, fungal infection may still present a problem in the severely ill or immunocompromised patient [@JR597-8].

PEG using the introducer technique, in which the gastrostomy tube does not pass through the oral cavity during placement, was first described by Hashiba in 1980 [@JR597-9]. It was also independently developed and described by Inoue and Russell later on in 1983 and 1984 respectively [@JR597-10] [@JR597-11]. This technique is extremely useful in patients with difficulty in opening their mouth or stenosis of the upper digestive tract such as head and neck cancer patients [@JR597-12]. While the pull or push techniques may not be feasible in up to 20 % of these patients, the introducer technique using an ultrathin endoscope transnasally not only increases the success rate of tube placement but also decreases the probability of tumor seeding during procedure [@JR597-13] [@JR597-14]. Furthermore, because the gastrostomy tube is inserted directly via the abdomen during placement, rates of peristomal site infection have been shown to be reduced in previous studies, including a recent meta-analysis [@JR597-15] [@JR597-16]. One study even concluded that the introducer technique can be performed without the need of prophylactic antibiotic administration [@JR597-17].

Although the safety of the introducer technique was greatly enhanced with the introduction of endoscopic gastropexy, one of the limitations of this technique was that almost all commercially available kits used small-caliber gastrostomy tubes of up to 15 Fr size, which may be associated with a higher risk of tube obstruction [@JR597-18] [@JR597-19]. In this study, we evaluated the safety and utility of a recently available large-caliber (20 Fr) introducer PEG kit with an improved puncture needle system compared to a similar size push technique kit used in our hospital.

Patients and methods
====================

Study design and patients
-------------------------

Prospectively collected data from patients who received PEG at our hospital between January 2014 and December 2015 was analyzed retrospectively. Only patients receiving tube placement for enteral feeding were included and after excluding 3 patients (1 patient because tube placement was for gastric decompression and 2 patients because of insufficient data), 136 patients (64 males and 72 females) were enrolled into this study. Data regarding baseline characteristics such as age, gender, comorbidities, and preoperative biomarkers (body mass index and blood laboratory markers collected on day of procedure) as well as postoperative findings such as hemodynamic changes immediately after procedure, changes in laboratory data on Day 7 after the procedure, postoperative adverse events (peristomal site infection, feeding-related pneumonia etc.) and clinical outcomes of interest (postoperative length of stay and mortality) were compared according to the different PEG techniques used. This study protocol was reviewed and approved by the ethics review committee of Hiroshima Kyoritsu Hospital. All patients, or their legal guardians, provided written informed consent for the procedures as well as enrolment into the study.

PEG tube insertion procedures
-----------------------------

All procedures were performed in our endoscopy center by at least 2 experienced gastroenterologists. Preoperative and postoperative protocols employed were the same no matter which insertion technique was used. Prophylactic antibiotics were administered in all patients (as required by existing protocols) but the use of conscious sedation with diazepam was left to the discretion of endoscopists, with careful monitoring of hemodynamic changes at all times during the procedure. Patients with antithrombotic therapy (using antiplatelet drugs or anticoagulants) were managed according to the latest guidelines established by the Japan Gastroenterological Endoscopy Society.

In the push technique, a 20 Fr tube (Safety PEG kit, Boston Scientific Corp., USA) is passed over a guidewire through the mouth into the stomach. This procedure is performed without gastropexy. It should be noted that although some previous studies have mistakenly used the term "push" method when they actually refer to the introducer technique, the push technique in this study refers to the technique originally described by Sacks and Vine in 1983 [@JR597-20]. For the introducer technique, a recently developed kit ([Fig. 1a](#FI597-1){ref-type="fig"}, Intolief PEG kit by Create Medic Co., Ltd, Yokohama, Japan) using a 20 Fr gastrostomy tube was used. This kit includes a Funada-style gastropexy device as well as a puncture needle/trocar ([Fig. 1b](#FI597-1){ref-type="fig"}) with a newly developed sleeve protection system to avoid mispuncture of the opposite stomach wall.

![New introducer PEG kit with **b** specialized puncture needle/trocar enlarged.](10-1055-s-0042-112587-i597ei1){#FI597-1}

[Fig. 2](#FI597-2){ref-type="fig"} is a pictorial diagram of the sleeve protection system during insertion of the puncture needle/trocar. The puncture needle is initially hidden under a protection sleeve before insertion ([Fig. 2a](#FI597-2){ref-type="fig"}). The penetrating edge of the puncture needle is exposed from the protection sleeve during insertion ([Fig. 2b](#FI597-2){ref-type="fig"}) but once resistance from the abdominal and gastric walls is absent, the protection sleeve covers the puncture needle, locking it in as the external peel-away sheath enters the gastric lumen ([Fig. 2c](#FI597-2){ref-type="fig"}). This not only helps avoid any accidental puncture into the opposing gastric wall but also decreases the risk of needle-stick injury in medical personnel.

![ Pictorial diagram showing insertion of puncture needle with protection sleeve.](10-1055-s-0042-112587-i597ei2){#FI597-2}

[Fig. 3](#FI597-3){ref-type="fig"} shows endoscopic imaging of PEG tube insertion with the introducer technique kit in a 79-year-old female under mechanical ventilation. After determining and sterilizing the puncture site, local anesthesia was applied and gastropexy performed. First, the double needle of the gastropexy device was inserted into the gastric lumen ([Fig. 3a](#FI597-3){ref-type="fig"}). After a loop snare was formed from the tip of one needle, a suture thread was inserted via the other ([Fig. 3b](#FI597-3){ref-type="fig"}). The suture thread was then caught by closing the loop snare and after the double needle was withdrawn from the stomach, the thread was tied outside the abdominal wall ([Fig. 3c](#FI597-3){ref-type="fig"}). This procedure was repeated at least 3 times surrounding the intended puncture site in a triangular pattern with a minimum distance of 2.0 cm apart in order to achieve stable gastropexy. After a 10 mm external incision was performed on the intended puncture site, the puncture needle/trocar (6.7 mm or 20 Fr) was then inserted ([Fig. 3 d](#FI597-3){ref-type="fig"}). Leaving only the external peel-away sheath, the puncture needle was removed and a 20 Fr gastrostomy tube was inserted via the sheath ([Fig. 3e](#FI597-3){ref-type="fig"}). After inflating the retention balloon with 10 mL of distilled water, the external sheath was peeled away to leave only the PEG tube in place ([Fig. 3f](#FI597-3){ref-type="fig"}).

![ Endoscopic imaging of tube insertion using the new introducer PEG kit with yellow arrows marking the visible gastropexy sutures.](10-1055-s-0042-112587-i597ei3){#FI597-3}

Although an ultrathin endoscope can be used transnasally for the introducer technique, procedures are usually performed by oral endoscopy. The choice of PEG kit is determined by the operator, influenced by preference or technical skills. Nonetheless, use of the introducer PEG kit is indicated in patients who cannot open their mouth and strongly recommended in cases where single endoscope insertions are thought to be preferable, such as patients with mechanical ventilation. PEG feeding usually begins 2 days after the procedure (using standard protocol) and patients are followed up by our nutrition support team where peristomal sites are also evaluated after 7 days. Peristomal infection was assessed using a previously validated scoring system (Jain's infection score) by assigning a score for erythema (0 to 4), induration (0 to 3) and exudate (0 to 4) [@JR597-21]. Infection was defined as development of pus or a combined infection score of 8 or more. Gastropexy sutures were kept in for at least 2 weeks after the procedure.

Statistical analysis
--------------------

Continuous variables are expressed as mean (standard deviation with range occasionally). Categorical (qualitative) variables are expressed as numbers (percentage). Comparisons for continuous variables were made using the Student *t*-test for normal data and the Mann-Whitney U test for non-parametric data. Tests for proportionality between groups were made using the chi-square test (or Fisher\'s exact test when indicated). Statistical significance was defined as *P* \< 0.05 and analysis was performed using XLSTAT2014 for Windows (Addinsoft Ltd., Paris, France).

Results
=======

In total, 136 patients were enrolled in the study. Seventy-five patients received tube placement with PEG kits using the push technique (Push kit) and 61 patients received placement with the new introducer PEG kit (Introducer kit). Baseline characteristics of patients (age, gender, comorbidities and preoperative biomarkers) are shown in [Table 1](#TB597-1){ref-type="table"}. The patients ranged in age from 59 years to 97 years and there were no significant differences in age or gender between the two groups. For comorbidities, although there were no differences in prevalence of stroke, neurodegenerative disorders, respiratory disorders, cardiovascular disorders, diabetes mellitus, pressure ulcers and malignancy between both groups, there were significantly more patients with dementia in the Push kit group when compared to the Introducer kit group (44 % vs. 21.3 %, *P* \< 0.01). As for preoperative biomarkers, there were no differences in body mass indices (BMI), white blood cell counts, hemoglobin levels, platelet counts, serum albumin levels, total lymphocyte counts, C-reactive protein levels, total cholesterol levels and blood urea nitrogen levels between the 2 groups. Although the use of antithrombotic therapy did not differ significantly between both groups, patients in the Push kit group had a higher international normalized ratio of prothrombin time (PT-INR) compared to those in the Introducer kit group (1.21 vs. 1.14, *P* = 0.02). Indications for PEG were primarily dysphagia secondary to neurological impairments or insufficient oral intake which may be due to various underlying conditions as listed in the comorbidities section ([Table 1](#TB597-1){ref-type="table"}).

###### Patient characteristics.

                                          Push kit(n = 75)       Introducer kit(n = 61)   *P*value
  --------------------------------------- ---------------------- ------------------------ ----------
  Age, years, mean (SD, range)            81.5 (9.7, 60 -- 97)   81.6 (7.7, 59 -- 95)     0.64
  Gender (male/female)                    34/41                  30/31                    0.73
  **Comorbidities**                                                                       
  Stroke, *n* (%)                         59 (78.7)              44 (72.1)                0.42
  Antithrombotic therapy,*n* (%)          29 (38.7)              17 (27.9)                0.21
  Dementia, *n* (%)                       33 (44)                13 (21.3)                \< 0.01
  Neurodegenerative disorders, *n* (%)    14 (18.7)              9 (14.8)                 0.65
  Respiratory disorders, *n* (%)          40 (53.3)              26 (42.6)                0.23
  Cardiovascular disorders, *n* (%)       24 (32)                23 (37.7)                0.59
  Diabetes mellitus, *n* (%)              16 (21.3)              19 (31.1)                0.24
  Malignancy, *n* (%)                     9 (12)                 8 (13.1)                 0.84
  **Preoperative biomarkers**                                                             
  Body mass index, kg/m^2^, mean (SD)     18.0 (3.5)             17.8 (3.0)               0.98
  White blood count, /μL, mean (SD)       7627 (2844)            7016 (2296)              0.27
  Hemoglobin, g/dL, mean (SD)             11.3 (1.8)             11.4 (1.9)               0.52
  Platelet count, × 10^4^/μL, mean (SD)   26.6 (9.8)             25.6 (8.9)               0.56
  Serum albumin, g/dL, mean (SD)          2.8 (0.6)              2.9 (0.5)                0.59
  TLC, /μL, mean (SD)                     1426 (793)             1555 (751)               0.29
  C-reactive protein, mg/dL, mean (SD)    2.1 (2.6)              2.5 (3.3)                0.99
  Total cholesterol, mg/dL, mean (SD)     151 (44)               150 (31)                 0.95
  Blood urea nitrogen, mg/dL, mean (SD)   24.8 (18.3)            22.5 (13.0)              0.54
  PT-INR, mean (SD)                       1.21 (0.23)            1.14 (0.10)              0.02

SD, standard deviation; TLC, total lymphocyte count; PT-INR, international normalized ratio of prothrombin time.

Tube placements were successful in all patients for both PEG kits and hemodynamic monitoring during procedure is summarized in [Table 2](#TB597-2){ref-type="table"}. Conscious sedation with diazepam was used in almost 75 % of patients in the Push kit group, which was significantly higher than the 57 % of patients in the Introducer kit group (*P* = 0.03). However, when used, the mean diazepam dosage did not differ significantly between the 2 groups. There were no significant differences in mean arterial pressure (MAP), pulse rate and saturation of peripheral oxygen (SpO^2^) at baseline when comparing both groups. Postoperative changes (the difference between values taken immediately after procedure and baseline) in hemodynamic markers were also insignificant between both groups although it should be noted that the increase in mean MAP for the Introducer kit group was slightly more prominent.

###### Hemodynamic monitoring during gastrostomy procedure.

                                                           Push kit(n = 75)   Introducer kit(n = 61)   *P*value
  -------------------------------------------------------- ------------------ ------------------------ ----------
  Use of sedation with diazepam, n (%)                     56 (74.7)          35 (57.4)                0.03
  Mean diazepam dosage used, mg                            4.2 (1.9)          3.9 (2.1)                0.25
  **Baseline**                                                                                         
  MAP, mmHg                                                93.1 (15.5)        93.1 (18.7)              0.61
  Pulse rate, beats per minute                             81.6 (15.7)        77.9 (13.4)              0.16
  SpO^2^, %                                                97.4 (2.3)         97.7 (2.7)               0.32
  **Postoperative change (immediately after procedure)**                                               
  ∆ MAP, mmHg                                              1.8 (18.9)         8.1 (19.4)               0.07
  ∆ Pulse rate, beats per minute                           4.6 (15.7)         4.9 (11.1)               0.71
  ∆ SpO^2^, %                                              -- 0.5 (2.8)       0.0 (2.6)                0.69

Values expressed as mean (SD) unless otherwise specified. MAP, mean arterial pressure; SpO^2^, saturation of peripheral oxygen.

Laboratory biomarkers were collected on postoperative Day 7 according to protocol and the differences from preoperative values are shown in [Table 3](#TB597-3){ref-type="table"}. The changes in hemoglobin levels, serum albumin levels, blood urea nitrogen as well as inflammatory markers such as white blood count and C-reactive protein levels were similar no matter which PEG kit was used.

###### Postoperative (at 7 day) change in laboratory biomarkers.

                                 Push kit(n = 75)   Introducer kit(n = 61)   *P*value
  ------------------------------ ------------------ ------------------------ ----------
  ∆ White blood count, /μL       212 (3443)         813 (2839)               0.26
  ∆ Hemoglobin, g/dL             -- 0.5 (0.9)       -- 0.6 (1.2)             0.84
  ∆ C-reactive protein, mg/dL    0.4 (3.2)          0.1 (4.1)                0.45
  ∆ Serum albumin, g/dL          -- 0.1 (0.3)       -- 0.1 (0.3)             0.70
  ∆ Blood urea nitrogen, mg/dL   -- 0.9 (14.7)      0.6 (6.9)                0.88

Values expressed as mean (SD).

[Table 4](#TB597-4){ref-type="table"} summarizes the postoperative adverse events and clinical outcomes after PEG tube placement. Feeding-related aspiration pneumonia (established by clinical symptoms as well as radiological findings) was the most common adverse event, followed by peristomal infection and feeding-related diarrhea. There were significantly fewer occurrences of aspiration pneumonia in the Introducer kit group compared to the Push kit group (8.2 % vs. 24 %, *P* = 0.02) and although not statistically significant, fewer cases of feeding-related diarrhea in the Introducer kit group as well. The frequency of peristomal infection was similar in both groups but the average Jain's infection score of patients in the Introducer kit group were significantly lower compared to the Push kit group (1.2 vs. 1.6, *P* \< 0.01). There were no significant differences in terms of accidental tube dislodgements, peritonitis and bleeding that required intervention (such as blood transfusion). No tube obstruction was observed in either groups during postoperative clinical course (up to day 90).

###### Postoperative adverse events and clinical outcomes

                                         Push kit(n = 75)   Introducer kit(n = 61)   *P*value
  -------------------------------------- ------------------ ------------------------ ----------
  **Postoperative adverse events**                                                   
  Feeding-related aspiration pneumonia   18 (24)            5 (8.2)                  0.02
  Peristomal infection                   10 (13.3)          7 (11.5)                 0.75
  Jain's infection score, mean (SD)      1.6 (1.5)          1.2 (1.5)                \< 0.01
  Feeding-related diarrhea               10 (13.3)          2 (3.3)                  0.06
  Accidental tube dislodgement           1 (1.3)            2 (3.3)                  0.59
  Peritonitis                            1 (1.3)            1 (1.6)                  1.00
  Bleeding                               3 (4)              1 (1.6)                  0.63
  Tube obstruction                       0 (0)              0 (0)                    N/A
  **Clinical outcomes**                                                              
  Length of stay, days, mean (SD)        23.7 (21.2)        16.0 (13.9)              0.01
  In-hospital mortality                  11 (14.7)          3 (4.9)                  0.06
  14-day mortality                       4 (5.3)            1 (1.6)                  0.38
  30-day mortality                       7 (9.3)            1 (1.6)                  0.07
  60-day mortality                       12 (16)            2 (3.3)                  0.02
  90-day mortality                       15 (20)            5 (8.2)                  0.05
  Procedure-related mortality            1 (1.3)            0 (0)                    1.00

Values expressed as n (%) unless otherwise specified. N/A: Not applicable.

Postoperative length of stay was significantly shorter in the Introducer kit group (16 days vs. 23.7 days, *P* = 0.01). There were also fewer mortalities (in-hospital, 14-day, 30-day, 60-day and 90-day) in the Introducer kit group with the 60-day mortality being significantly lower compared to the Push kit group (3.3 % vs. 16 %, *P* = 0.02). There was one procedure-related death in the Push kit group (due to excessive bleeding) but the main contributor to all mortality was aspiration pneumonia secondary to gastroesophageal reflux of feed.

Discussion
==========

For long-term enteral tube feeding, PEG has been established as a safe and simple procedure. Although the pull or push technique remains the most popular method for gastrostomy tube placement, the need of passing the tube through the oral cavity increases the risk of peristomal site infection and negatively affects the success rate of tube placement in patients with upper digestive tract stenosis or trismus.

PEG using the introducer technique is an alternative method for gastrostomy tube placement which does not require tube transit orally. Unlike the pull or push technique, the procedure requires only single insertion of the endoscope and the endoscopist is required to just observe during insertion. However due to several reasons, this method of tube placement is not as widely employed as the pull or push technique. First of all, initial versions of the introducer technique did not use gastropexy, which while making the procedure simpler and faster, also caused adverse events such as displacement of the gastric wall due to trocar insertion or accidental tube dislodgement, which in turn resulted in leakage of stomach contents into the peritoneum and procedural failure [@JR597-22] [@JR597-23]. The introduction of gastropexy before tube placement greatly enhanced the safety of the introducer technique [@JR597-24] [@JR597-25]. However, the need for gastropexy and gastropexy-related devices not only increased total procedure time but also the price of introducer PEG kits [@JR597-17] [@JR597-26] [@JR597-27]. Furthermore, almost all commercially available kits use small-caliber gastrostomy tubes of up to 15 Fr, which may lead to frequent episodes of tube obstruction. Tube size is also a matter of concern in Japan where the use of semi-solid feed or blended food is quite common to help prevent gastroesophageal reflux and other feeding-related adverse events [@JR597-28] [@JR597-29].

The modified introducer technique (also called the direct method) was developed in 2001 and enabled the placement of large-caliber gastrostomy tubes up to 24 Fr [@JR597-30] [@JR597-31]. However, this modification actually made the procedure more complex due to the need of puncture site dilation. Prices of modified introducer PEG kits are also more expensive than the original introducer PEG kits. Recently however, an introducer technique using a new large-caliber trocar to insert gastrostomy tubes up to 20 Fr was reported [@JR597-32]. Although the trocar size is similar to the one used in this study, it lacked the safety features of the sleeve protection system described herein.

This is the first study evaluating the safety and utility of a recently developed large-caliber (20 Fr) introducer PEG kit with an improved puncture needle using a sleeve protection system. As far as we are aware, this is also the first study comparing the introducer technique and the push technique using gastrostomy tubes of the same size. Although this is a retrospective non-randomized study, other than the prevalence of dementia, patients in both groups were comparable in terms of baseline characteristics such as age, gender and other comorbidities. Preoperative biomarkers also did not differ significantly in both groups except for PT-INR, which was slightly higher in the Push kit group. Although the higher PT-INR may have indirectly contributed to more incidence of bleeding (including 1 procedure-related death) in the Push kit group, it should be noted that the average values for both groups were well within guideline-acceptable levels. As shown in [Table 3](#TB597-3){ref-type="table"}, postoperative changes in hemoglobin levels on Day 7 also did not differ significantly between the 2 groups, although the use of blood transfusion was not taken into consideration during analysis.

In this study, postoperative changes in data were used to reflect the changes from baseline, meaning that a positive value would indicate an increase and vice versa. Hemodynamic changes during procedure ([Table 2](#TB597-2){ref-type="table"}) and postoperative changes in laboratory biomarkers 7 days after procedure ([Table 3](#TB597-3){ref-type="table"}) indicate that the use of the introducer PEG kit was well tolerated by patients. The use of sedation (not the dosage however) was significantly lower in the Introducer kit group presumably because only single insertion of endoscope was required. This may have influenced the postoperative changes in hemodynamics such as MAP, albeit not to a statistically significant degree when compared to the Push kit group. 

As for postoperative adverse events, the Introducer kit group fared better when it came to feeding-related events such as aspiration pneumonia and diarrhea (for diarrhea, not statistically significant) despite both groups being similar in terms of preoperative nutritional biomarkers and having the same feeding protocols. However, because patients in this study were not randomized accordingly, these favorable outcomes could have resulted from selection bias. Although the occurrence of peristomal infection did not differ significantly between the two groups, in agreement with earlier studies, patients in the Introducer kit group had significantly lower infection scores compared to the Push kit group. Previous studies have also reported higher rates of accidental tube dislodgement (removal) in patients receiving tube placement using the introducer technique [@JR597-19] [@JR597-33]. Although we contend that the higher rates may be due to the type of gastrostomy tube (balloon-type) employed rather than the insertion technique itself, in this study, tube dislodgements were not significantly higher in the Introducer kit group. Interestingly, the incidence of bleeding was also not higher in the Introducer kit group although gastropexy (meaning more percutaneous gastric punctures) was required.

Postoperative length of stay was significantly lower and there were fewer mortalities in the Introducer kit group, with statistical significance at the 60-day mortality point. This is most probably because patients in the Introducer kit group experienced fewer adverse events compared to their Push kit group counterparts. Notable limitations of this study include its retrospective design with a high probability of selection bias even though baseline characteristics and biomarkers were reasonably comparable between the 2 groups. The study also lacks long term follow-up data beyond 90 days (which is still in progress as an ongoing observational study).

It may be worth mentioning that in Japan, regular gastrostomy tube replacement (every 3 to 4 months) is common to prevent tube obstruction and other long-term tube-related problems. Gastrostomy tubes placed using the pull or push techniques usually have internal mushroom-like bumpers which often require endoscopic removal for optimal safety during replacement while tubes placed using the introducer technique uses retention balloons which upon deflation can be safely and easily replaced without endoscopic intervention. Therefore, using the introducer PEG kits may also help reduce the cost of initial tube replacements.

Conclusions
===========

In conclusion, retrospective evaluation of the safety and utility of a novel large-caliber introducer PEG kit with an improvised puncture needle/trocar showed that gastrostomy tubes placed using the new kit produced non-inferior (with some favourable) results when compared to push PEG kits of similar tube size. We also contend that the new kit would be very useful, especially in patients with esophageal stenosis, since using the large-caliber tubes will help maintain the same tube patency as tubes inserted using the conventional pull/push techniques. Balloon type catheters also allow tube exchange without the need for an endoscopic examination. Although the new introducer PEG kit is considered safe to use, the final choice of gastrostomy tube placement method should be made after taking into consideration patient's circumstances (giving priority to cases with trismus or upper digestive tract stenosis) as well as operator's technical preference.
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